Publications by authors named "Ponego L Ponatshego"

Claim this Profile
M
Moderate agreement between the spot albumin‒Creatinine ratio (ACR) and urine albumin (UA) among virally suppressed adults living with HIV in botswana: a cross sectional study.
Mosepele Mosepele, Ponego L Ponatshego, Kesaobaka Molebatsi, Kago Kebotsamang, Christopher Williams

AIDS Res Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety and Tolerability of Dispersible and Immediate Release Abacavir/Dolutegravir/Lamivudine Tablets in Children With HIV: IMPAACT 2019 Week 48 Results.
Helena Rabie, Dwight E Yin, Shawn Ward, Yasha Rani, Lauren Ziemba, Ponego L Ponatshego

Pediatr Infect Dis J· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study.
Kristina M Brooks, Jennifer J Kiser, Lauren Ziemba, Shawn Ward, Yasha Rani, Ponego L Ponatshego

Lancet HIV· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographical Differences in the Self-Reported Functional Impairment of People With Human Immunodeficiency Virus (HIV) and Associations With Cardiometabolic Risk.
Kristine M Erlandson, Kathleen V Fitch, Sara A McCallum, Heather J Ribaudo, Edgar T Overton, Ponego L Ponatshego

Clin Infect Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current co-morbidities burden in patients living with HIV in low- and middle-income countries.
Ponego Lloyd Ponatshego, Nabila Farah Youssouf, Mosepele Mosepele

Curr Opin HIV AIDS· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study.
Ponego Lloyd Ponatshego, David Stephen Lawrence, Nabila Youssouf, Sile F Molloy, Melanie Alufandika

BMJ Open· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis